Zoé L. E. van Kempen

Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies

Laura Boekel, Maurice Steenhuis, Femke Hooijberg et al. · The Lancet Rheumatology · 2021 · 170 citations · Full text

Perspective of patients with autoimmune diseases on COVID-19 vaccination

Laura Boekel, Femke Hooijberg, Zoé L. E. van Kempen et al. · The Lancet Rheumatology · 2021 · 91 citations · Full text

COVID-19 in multiple sclerosis: The Dutch experience

Floor C. Loonstra, Elske Hoitsma, Zoé L. E. van Kempen et al. · Multiple Sclerosis Journal · 2020 · 78 citations · Full text

Ms Patients, Intensive Care Unit, Long Covid +14

Personalized B-cell tailored dosing of ocrelizumab in patients with multiple sclerosis during the COVID-19 pandemic

Zoë YGJ van Lierop, Alyssa A Toorop, Wouter JC van Ballegoij et al. · Multiple Sclerosis Journal · 2021 · 66 citations · Full text

Personalized extended interval dosing of natalizumab in MS

Zoé L. E. van Kempen, E.L.J. Hoogervorst, Mike P. Wattjes et al. · Neurology · 2020 · 52 citations · Full text